Virtuoso Therapeutics
Virtuoso Therapeutics is a biopharmaceutical company advancing a pipeline of novel bispecific antibodies to treat cancer. Using a differentiated approach to antibody engineering, the company designs molecules intended to overcome the limitations of existing therapies and to address major hurdles facing emerging classes of oncology treatments. Virtuoso is a venture-backed portfolio company of Canaan Partners. This profile is maintained in the API Evangelist network; the company currently publishes no public API or developer surface.
Virtuoso Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Oncology, and Antibodies.
Virtuoso Therapeutics’ developer surface includes engineering blog and 4 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Company 3
The organization behind the API